Previous close | 193.00 |
Open | 192.00 |
Bid | 193.00 x 10000 |
Ask | 196.00 x 10000 |
Day's range | 192.00 - 192.00 |
52-week range | 167.00 - 246.00 |
Volume | |
Avg. volume | 0 |
Market cap | 9.108B |
Beta (5Y monthly) | 1.12 |
PE ratio (TTM) | 27.12 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.25 (0.65%) |
Ex-dividend date | 29 Feb 2024 |
1y target est | N/A |
Teleflex's (TFX) new UroLift 2 System with the ATC platform is designed to treat all prostate types.
Key Insights The projected fair value for Teleflex is US$354 based on 2 Stage Free Cash Flow to Equity Teleflex's...
Investors are optimistic about Teleflex (TFX) on robust growth in the Vascular business and strong Urolift prospects.